Interleukin-1β and interleukin-6 gene polymorphisms as risk factors for AD: A prospective study

Experimental Gerontology

Volumn 41, Issue 1, 2006, Pages 85-92

  Ravaglia, Giovanni ^a   Paola, Forti ^a   Maioli, Fabiola ^a   Martelli, Mabel ^a   Montesi, Fausta ^a   Bastagli, Luciana ^a   Bianchin, Marisa ^b   Chiappelli, Martina ^c   Tumini, Emanuela ^c   Bolondi, Luigi ^a   Licastro, Federico ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b District Health Unit of Lugo   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Alzheimer disease; Genetic polymorphism; Inflammation; Interleukin 1 ; Interleukin 6; Prospective study

Indexed keywords

APOLIPOPROTEIN E4; GUANINE NUCLEOTIDE; HOMOCYSTEINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PYRIMIDINE NUCLEOTIDE; APOLIPOPROTEIN E; INTERLEUKIN 1;

AGED; ALLELE; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; AMINO ACID SUBSTITUTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; BLOOD; DEMENTIA; GENETIC PREDISPOSITION; GENETICS; PROSPECTIVE STUDY; REVIEW;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; DEMENTIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMOCYSTEINE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 29744469446     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2005.10.005     Document Type: Article

References (43)

1. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. Frautschy, W.S. Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I.R. Mackenzie, P.L. McGeer, M.K. O'Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F.L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk, and T. Wyss-Coray Inflammation and Alzheimer's disease Neurobiol. Aging 21 2000 383 421
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-IV 4th ed. 1994 American Psychiatric Association Washington, DC
3. B. Arosio, D. Trabattoni, L. Galimberti, P. Bucciarelli, F. Fasano, C. Calabresi, C.L. Cazzullo, C. Vergani, G. Annoni, and M. Clerici Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease Neurobiol. Aging 25 2004 1009 1015
4. M. Bagli, A. Papassotiropoulos, M. Knapp, F. Jessen, M. Luise Rao, W. Maier, and R. Heun Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population Neurosci. Lett. 283 2000 109 112
5. T.J. Bhojak, S.T. DeKosky, M. Ganguli, and M.I. Kamboh Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease Neurosci. Lett. 288 2000 21 24
6. C. Capurso, V. Solfrizzi, A. D'Introno, A.M. Colacicco, S.A. Capurso, A. Capurso, and F. Panza Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe Exp. Gerontol. 39 2004 1567 1573
7. G.A. Carlesimo, C. Caltagirone, and G. Gainotti The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The group for the standardization of the mental deterioration battery Eur. Neurol. 36 1996 378 384
8. O. Combarros, A. Alvarez-Arcaya, M. Sanchez-Guerra, J. Infante, and J. Berciano Candidate gene association studies in sporadic Alzheimer's disease Dement. Geriatr. Cogn. Disord. 14 2002 41 54
9. A. Coppola, C. Astarita, E. Liguori, D. Fontana, M. Oliviero, K. Esposito, L. Coppola, and D. Giugliano Impairment of coronary circulation by acute hyperhomocysteinaemia and reversal by antioxidant vitamins J. Intern. Med. 256 2004 398 405
10. C. Depboylu, F. Lohmuller, P. Gocke, Y. Du, R. Zimmer, T. Gasser, T. Klockgether, and R.C. Dodel An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease Dement. Geriatr. Cogn. Disord. 17 2004 170 173
11. F.S. di Giovine, E. Takhsh, A.I. Blakemore, and G.W. Duff Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta) Hum. Mol. Genet. 1 1992 450
12. F. Faltraco, K. Burger, P. Zill, S.J. Teipel, H.J. Moller, H. Hampel, B. Bondy, and M. Ackenheil Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk J. Am. Geriatr. Soc. 51 2003 578 579
13. A.L. Fitzpatrick, L.H. Kuller, D.G. Ives, O.L. Lopez, W. Jagust, J.C. Breitner, B. Jones, C. Lyketsos, and C. Dulberg Incidence and prevalence of dementia in the cardiovascular health study J. Am. Geriatr. Soc. 52 2004 195 204
14. M. Ganguli, H.H. Dodge, P. Chen, S. Belle, and S.T. DeKosky Ten-year incidence of dementia in a rural elderly US community population: the MoVIES project Neurology 54 2000 1109 1116
15. L.M. Grimaldi, V.M. Casadei, C. Ferri, F. Veglia, F. Licastro, G. Annoni, I. Biunno, G. De Bellis, S. Sorbi, C. Mariani, N. Canal, W.S. Griffin, and M. Franceschi Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism Ann. Neurol. 47 2000 361 365
16. R. Hedley, J. Hallmayer, D.M. Groth, W.S. Brooks, S.E. Gandy, and R.N. Martins Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia Ann. Neurol. 51 2002 795 797
17. D.W. Hosmer, and S. Lemeshow Applied Logistic Regression 1989 Wiley New York
18. A.F. Jorm, H. Christensen, A.E. Korten, P.A. Jacomb, and A.S. Henderson Informant ratings of cognitive decline in old age: validation against change on cognitive tests over 7 to 8 years Psychol. Med. 30 2000 981 985
19. F. Licastro, S. Pedrini, C. Ferri, V. Casadei, M. Govoni, A. Pession, F.L. Sciacca, F. Veglia, G. Annoni, M. Bonafe, F. Olivieri, C. Franceschi, and L.M. Grimaldi Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk Ann. Neurol. 48 2000 388 391
20. F. Licastro, L.M. Grimaldi, M. Bonafe, C. Martina, F. Olivieri, L. Cavallone, S. Giovanietti, E. Masliah, and C. Franceschi Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain Neurobiol. Aging 24 2003 921 926
21. F. Licastro, M. Chiappelli, C.M. Caldarera, C. Tampieri, S. Nanni, M. Gallina, and A. Branzi The concomitant presence of polymorphic alleles of interleukin-1beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men Results from a pilot study. Mech. Ageing Dev. 125 2004 575 579
22. E. Magni, G. Binetti, A. Bianchetti, R. Rozzini, and M. Trabucchi Mini-mental state examination: a normative study in an Italian elderly population Eur. J. Neurol. 3 1996 1 5
23. P.L. McGeer, and E.G. McGeer Inflammation, autotoxicity and Alzheimer disease Neurobiol. Aging 22 2001 799 809
24. P.L. McGeer, and E.G. McGeer Polymorphisms in inflammatory genes and the risk of Alzheimer disease Arch. Neurol. 58 2001 1790 1792
25. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzhimer's Disease Neurology 34 1984 939 944
26. R.L. Minster, S.T. DeKosky, M. Ganguli, S. Belle, and M.I. Kamboh Genetic association studies of interleukin-1 (IL-1A and IL-1B) and interleukin-1 receptor antagonist genes and the risk of Alzheimer's disease Ann. Neurol. 48 2000 817 819
27. M.S. Morris Homocysteine and Alzheimer's disease Lancet Neurol. 2 2003 425 428
28. R.C. Petersen Mild cognitive impairment as a diagnostic entity J. Intern. Med. 256 2004 183 194
29. R. Pola, A. Flex, E. Gaetani, A.D. Lago, L. Gerardino, P. Pola, and R. Bernabei The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population Neuroreport 13 2002 1645 1647
30. G. Ravaglia, P. Forti, F. Maioli, L. Sacchetti, E. Mariani, V. Nativio, T. Talerico, C. Vettori, and P.L. Macini Education, occupation, and prevalence of dementia: findings from the Conselice study Dement. Geriatr. Cogn. Disord. 14 2002 90 100
31. G. Ravaglia, P. Forti, F. Maioli, M. Martelli, L. Servadei, N. Brunetti, E. Porcellini, and F. Licastro Homocysteine and folate as risk factors for dementia and Alzheimer disease Am. J. Clin. Nutr. 82 2005 636 643
32. G. Ravaglia, P. Forti, F. Maioli, M. Martelli, L. Servadei, N. Brunetti, E. Dalmonte, M. Bianchin, and E. Mariani Incidence and etiology of dementia in a large elderly Italian population Neurology 64 2005 1525 1530
33. R.E. Ready, B.R. Ott, and J. Grace Validity of informant reports about AD and MCI patients' memory Alzheimer Dis. Assoc. Disord. 18 2004 11 16
34. H. Refsum, A.D. Smith, P.M. Ueland, E. Nexo, R. Clarke, J. McPartlin, C. Johnston, F. Engbaek, J. Schneede, C. McPartlin, and J.M. Scott Facts and recommendations about total homocysteine determinations: an expert opinion Clin. Chem. 50 2004 3 32
35. G.C. Roman, T.K. Tatemichi, T. Erkinjuntti, J.L. Cummings, J.C. Masdeu, J.H. Garcia, L. Amaducci, J.M. Orgogozo, A. Brun, and A. Hofman Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop Neurology 43 1993 250 260
36. D. Seripa, M.G. Matera, G. Dal Forno, C. Gravina, C. Masullo, A. Daniele, G. Binetti, C. Bonvicini, R. Squitti, M.T. Palermo, D.G. Davis, P. Antuono, D.R. Wekstein, A. Dobrina, M. Gennarelli, and V.M. Fazio Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients Neurobiol. Aging 26 2005 455 464
37. N. Shibata, T. Ohnuma, T. Takahashi, H. Baba, T. Ishizuka, M. Ohtsuka, A. Ueki, M. Nagao, and H. Arai Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases Am. J. Med. Genet. 114 2002 436 439
38. The Canadian Study of Health and Aging Working Group The incidence of dementia in Canada Neurology 55 2000 66 73
39. The Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke. A meta-analysis JAMA 288 2002 2015 2022
40. P.M. Ueland, S. Hustad, J. Schneede, H. Refsum, and S.E. Vollsetm Biological and clinical implications of the MTHFR C677T polymorphism Trends Pharmacol. Sci. 22 2001 195 201
41. L. Waite, D. Grayson, A.F. Jorm, H. Creasey, J. Cullen, H. Bennett, B. Casey, and G.A. Broe Informant-based staging of dementia using the clinical dementia rating Alzheimer Dis. Assoc. Disord. 13 1999 34 37
42. W.F. Wang, Y.C. Liao, S.L. Wu, F.J. Tsai, C.C. Lee, and C.S. Hua Association of Interleukin-1 beta and receprto antagonist gene polymoprhisms with late onset Alzheimer's disease in Taiwan Chinese Eur. J. Neurol. 12 2005 609 613
43. Y. Zhang, A. Hayes, A. Pritchard, U. Thaker, M.S. Haque, H. Lemmon, J. Harris, A. Cumming, J.C. Lambert, M.C. Chartier-Harlin, D. St Clair, T. Iwatsubo, D.M. Mann, and C.L. Lendon Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease Neurosci. Lett. 362 2004 99 102